Elan Announces Availability of Information Statement in Respect of Prothena Corporation plc
Elan Announces Availability of Information Statement in Respect of Prothena Corporation plc
DUBLIN--(BUSINESS WIRE)-- Elan Corporation, plc (NYS: ELN) announces that the information statement in respect of Prothena Corporation plc, which is being provided to holders of record of Elan ordinary shares and ADSs as of December 14, 2012 and which describes the separation and distribution of the Prothena Business in detail and contains important business and financial information about Prothena, has been published. The information statement is now available on Elan's website at www.elan.com.
About Elan
Elan Corporation, plc (NYS: ELN) is a neuroscience-based biotechnology company committed to making a difference in the lives of patients and their families by dedicating itself to bringing innovations in science to fill significant unmet medical needs that continue to exist around the world. Elan shares trade on the New York and Irish Stock Exchanges. For additional information about the Company, please visit www.elan.com.
Elan Corporation, plc
Investor Relations:
Chris Burns, 800-252-3526
David Marshall, 353-1-709-4444
Media Relations:
Emer Reynolds, + 353-1-709-4022
Jonathan Birt, +44-751-559-7858
KEYWORDS: Europe Ireland
INDUSTRY KEYWORDS:
The article Elan Announces Availability of Information Statement in Respect of Prothena Corporation plc originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.
